Abstract
Along the last 8 years, the National Institute of Science and Technology of Bioethanol (INCT-Bioetanol) reached several important milestones towards the main objective of producing second-generation bioethanol from sugarcane bagasse. The sugarcane cell wall structure and architecture is now better understood, dozens of new cell wall hydrolases had their genes and enzymes fully characterized, sugargane physiology and its responses to climate change were investigated, and novel yeast strains capable to metabolize pentoses have been discovered. At the same time, history and politics involved in sugarcane as a bioenergy source have been studied and revised. Thus, simultaneously with other large bioenergy programs in the USA and Europe that were set up to improve renewable energy production, the INCT-Bioetanol in Brazil managed to produce important data in basic research. All this data is expected to help industry to produce not only more ethanol, but also new biomaterials to foster bioeconomy. This book reports some of these findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Buckeridge MS, Goldman GH (2011) Routes to cellulosic ethanol. Springer, New York, 270 p
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Buckeridge, M.S., De Souza, A.P. (2017). Routes to Second-Generation Bioethanol in Brazil: Foundation of the National Institute of Science and Technology of Bioethanol. In: Buckeridge, M., De Souza, A. (eds) Advances of Basic Science for Second Generation Bioethanol from Sugarcane. Springer, Cham. https://doi.org/10.1007/978-3-319-49826-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-49826-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49824-9
Online ISBN: 978-3-319-49826-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)